Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

宜 昌 東 陽 光 長 江 藥 業 股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 01558)

NOTICE OF 2021 FIRST H SHAREHOLDERS CLASS MEETING

NOTICE IS HEREBY GIVEN that the 2021 first H shareholders class meeting (the ''2021 First H Shareholders Class Meeting'') of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (the ''Company'') will be held at Conference Room, 4/F, Administration Building, Dongyangguang Scientific Park, No. 368 Zhen An Zhong Road, Chang'an County, Dongguan, Guangdong Province, the People's Republic of China, at 11:00 a.m. on Friday, 4 June 2021 (or immediately after the conclusion of the annual general meeting of the Company to be convened on the same day or any adjournment thereof) to consider and, if thought fit, to approve the following resolution. Unless otherwise defined, capitalized terms used herein shall have the same meanings as those defined in the circular of the Company dated 16 April 2021 (the ''Circular'').

SPECIAL RESOLUTION

1. To consider and approve the general mandates to the Board to repurchase H Shares.

Details of the above resolution submitted to the 2021 First H Shareholders Class Meeting are set out in the Circular and is available for viewing on the website of the Stock Exchange (www.hkexnews.hk) and the website of the Company (www.hec-changjiang.com).

On behalf of the Board

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

TANG Xinfa

Chairman

Hubei, the PRC

16 April 2021

- 1 -

Notes:

  1. In order to determine the list of Shareholders who will be entitled to attend and vote at the 2021 First H Shareholders Class Meeting of the Company to be held on Friday, 4 June 2021, the H share registers of members of the Company will be closed from Tuesday, 1 June 2021 to Friday, 4 June 2021 (both days inclusive), during which period no transfer of shares will be effected. Shareholders whose names appear on the H share registers of members of the Company at the close of business on Monday, 31 May 2021 shall be entitled to attend and vote at the 2021 First H Shareholders Class Meeting. In order for the H Shareholders to qualify to attend and vote at the 2021 First H Shareholders Class Meeting, all transfer documents accompanied by the relevant share certificates must be lodged with the Company's H share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong, for holders of H Shares no later than 4:30 p.m. on Monday, 31 May 2021 for registration.
  2. H Shareholders may, by completing the form of proxy of the Company, appoint one or more proxies to attend and vote at the 2021 First H Shareholders Class Meeting (or any adjournment thereof) on his behalf. A proxy needs not be a Shareholder.
  3. H Shareholders must use the form of proxy of the Company for appointing a proxy and the appointment must be in writing. The form of proxy must be signed by the relevant H Shareholder or by a person duly authorized by the relevant H Shareholder in writing (''power of attorney''). If the form of proxy is signed by the person authorized by the relevant H Shareholder as aforesaid, the relevant Power of Attorney and other relevant documents of authorization (if any) must be notarized. If a corporate H Shareholder appoints a person other than its legal representative to attend the 2021 First H Shareholders Class Meeting (or any adjournment thereof) on its behalf, the relevant form of proxy must be affixed with the company seal of the corporate H Shareholder or duly signed by its director or any other person duly authorized by that corporate H Shareholder as required by the articles of association of the company.
  4. To be valid, the form of proxy and the relevant notarized Power of Attorney (if any) and other relevant documents of authorization (if any) as mentioned in note 3 above must be delivered to the Company's H share registrar, Computershare Hong Kong Investor Services Limited at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong not less than 24 hours before the time appointed for the 2021 First H Shareholders Class Meeting (or any adjournment thereof) (i.e. before 11:00 a.m. on Thursday, 3 June 2021).
  5. H Shareholder or his proxy should produce proof of identity when attending the 2021 First H Shareholders Class Meeting (or any adjournment thereof). If a corporate H Shareholder's legal representative or any other person duly authorized by such corporate H Shareholder attends the 2021 First H Shareholders Class Meeting (or any adjournment thereof), such legal representative or other person shall produce his proof of identity, and proof of designation as a legal representative or the valid authorization document (as the case may be).
  6. The 2021 First H Shareholders Class Meeting (or any adjournment thereof) is expected to last less than one day. H Shareholders or their proxies who attend the 2021 First H Shareholders Class Meeting (or any adjournment thereof) shall bear their own travelling, meal and accommodation expenses.
  7. The address of the Company's H share registrar, Computershare Hong Kong Investor Services Limited is:
    Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wan Chai, Hong Kong Tel No.: 852-2862-8555
    Fax No.: 852-2865-0990
  8. Pursuant to Rule 13.39(4) of the Listing Rules, any vote of shareholders at a general meeting must be taken by poll except where the chairman of the general meeting, in good faith, decides to allow a resolution which relates purely to a procedural or administrative matter to be voted on by a show of hands.

As at the date of this notice, the Board consists of Mr. JIANG Juncai, Mr. WANG Danjin, Mr. CHEN Yangui and Mr. LI Shuang as executive Directors; Mr. TANG Xinfa and Mr. Eddy HUANG as non-executive Directors; and Mr. TANG Jianxin, Mr. ZHAO Dayao, Ms. XIANG Ling and Mr. LI Xuechen as independent non-executive Directors.

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

Yichang Hec Changjiang Pharmaceutical Co. Ltd. published this content on 15 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2021 09:14:06 UTC.